Marie Tecnimont, Newcleo Team Up to Produce Carbon-Neutral Hydrogen
(Reuters) — Newcleo has signed an agreement with Maire Tecnimont's units NextChem Tech and Tecnimont to use its nuclear reactors to decarbonize the chemical industry, including hydrogen production, the two companies said on Wednesday.
Newcleo, which was founded by Italian physicist and alumnus of the European Organization for Nuclear Research (CERN) Stefano Buono, is developing fourth-generation small modular reactors to produce nuclear energy.
"Small or advanced modular reactors have the potential not only to serve electricity production, but also to have industrial applications," Newcleo Chairman and CEO Buono said in a statement.
The agreement will enable the production of electrolytic hydrogen and sustainable chemicals, including carbon-neutral ammonia, methanol, e-fuels and derivatives, the two companies said.
In addition, Tecnimont will provide high-level consultancy services for Newcleo to develop power plants based on the start-up's small modular lead-cooled fast reactor powered with reprocessed nuclear waste.
Milan-based Maire Tecnimont is present in 45 countries and focuses on building plants for the petrochemicals, refining and fertilizer industries.
Related News
Related News

- Kinder Morgan Proposes 290-Mile Gas Pipeline Expansion Spanning Three States
- Valero Plans to Shut California Refinery, Takes $1.1 Billion Hit
- Three Killed, Two Injured in Accident at LNG Construction Site in Texas
- Tallgrass to Build New Permian-to-Rockies Pipeline, Targets 2028 Startup with 2.4 Bcf Capacity
- TC Energy Approves $900 Million Northwoods Pipeline Expansion for U.S. Midwest
- U.S. Pipeline Expansion to Add 99 Bcf/d, Mostly for LNG Export, Report Finds
- Enbridge Adds Turboexpanders at Pipeline Sites to Power Data Centers in Canada, Pennsylvania
- Great Basin Gas Expansion Draws Strong Shipper Demand in Northern Nevada
- Cheniere Seeks FERC Approval to Expand Sabine Pass LNG Facility
- US Poised to Become Net Exporter of Crude Oil in 2023
Comments